-
2601por da Costa-Val, Adriane Pimenta, Cavalcanti, Reginaldo Roris, de Figueiredo Gontijo, Nelder, Marques Michalick, Marilene Suzan, Alexander, Bruce, Williams, Paul, Melo, Maria NormaEnlace del recurso
Publicado 2007
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2602por Baghad, Bouchra, Razanapinaritra, Rojosoa, Maksouri, Hasnaa, El Bouri, Hicham, Outlioua, Ahmed, Fellah, Hassan, Lemrani, Meryem, Akarid, Khadija, Martin-Sanchez, Joaquina, Chiheb, Soumiya, Riyad, Myriam“…The heterogeneity of these diseases is influenced by both parasitic properties and host factors. Cutaneous leishmaniasis (CL) is a major public health problem in Morocco, where the geographical expansion of CL (particularly CL caused by Leishmania tropica), the heterogeneous appearance of lesions and the difficulty in diagnosing CL contribute to late diagnosis of CL and delayed treatment of patients. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2603por Lewis, Michael D., Paun, Andrea, Romano, Audrey, Langston, Harry, Langner, Charlotte A., Moore, Ian N., Bock, Kevin W., Francisco, Amanda Fortes, Brenchley, Jason M., Sacks, David L.“…Leishmania donovani causes visceral leishmaniasis (VL), which is typically fatal without treatment. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2604por Ahmed, Ahmed A., Rasheed, Zafar, Salem, Tarek, Al-Dhubaibi, Mohammed S., Al Robaee, Ahmad A., Alzolibani, Abdullateef A.“…BACKGROUND: Cutaneous leishmaniasis (CL) is well linked with immunogenetic factors. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2605“…The protozoans Leishmania and Trypanosoma, belonging to the same Trypanosomatidae family, are the causative agents of Leishmaniasis, Chagas disease, and human African trypanosomiasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2606por Kurizky, Patrícia Shu, Marianelli, Fernanda Ferraço, Cesetti, Mariana Vicente, Damiani, Giovanni, Sampaio, Raimunda Nonata Ribeiro, Gonçalves, Lais Mitsue Tanaka, de Sousa, Carlos Augusto Felipe, Martins, Sofia Sales, Vernal, Sebastian, da Mota, Licia Maria Henrique, Gomes, Ciro Martins“…Immunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2607por ESLAMI, Gilda, FATTAHI BAFGHI, Ali, LOTFI, Mohammad Hassan, MIRZAEI, Farzaneh, AHMADI, Somayeh, TAJFIROUZEH, Ali Akbar, JAFARIZADEH, Hamid, PORMAZAR, Sayyed Alireza, VAKILI, Mahmoud“…BACKGROUND: Cutaneous Leishmaniasis (CL) is a major health problem in many parts of Iran. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2608por Bengtson, Michel, Bharadwaj, Mitasha, Bosch, Astrid ten, Nyakundi, Hellen, Matoke-Muhia, Damaris, Dekker, Cees, Diehl, Jan-Carel“…As a case study, we focus on the diagnosis of visceral leishmaniasis (VL) in rural resource-limited regions of Kenya and Uganda. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2609por AHMADI-HAMEDANI, Mahmooud, HOSSEINPOUR, Hediyeh, ESKAFIAN, Hesamodin, DAVARPANAH, Shayan“…Cutaneous involvement in canine leishmaniasis, caused by Leishmania infantum, is the most frequent clinical manifestation of the zoonotic infectious disease. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2610por Rancan, Eduardo Alexandre, Chagas, Eduardo Federighi Baisi, Sperança, Márcia Aparecida, Carvalho, Valeria Camargo de Lacerda, Martins, Luciamáre Perinetti Alves, Suzuki, Rodrigo Buzinaro“…Nowadays visceral leishmaniasis is widespread in Brazil and the Adamantina microregion, located in the west of Sao Paulo State, has been affected by Human American Visceral Leishmaniasis (HAVL) since 2004. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2611por Thomas, Michael G., De Rycker, Manu, Ajakane, Myriam, Crouch, Sabrinia D., Campbell, Lorna, Daugan, Alain, Fra, Gloria, Guerrero, César, Mackenzie, Claire J., MacLean, Lorna, Manthri, Sujatha, Martin, Franck, Norval, Suzanne, Osuna-Cabello, Maria, Riley, Jennifer, Shishikura, Yoko, Miguel-Siles, Juan, Simeons, Frederick R. C., Stojanovski, Laste, Thomas, John, Thompson, Stephen, Velasco, Raul F., Fiandor, Jose M., Wyatt, Paul G., Read, Kevin D., Gilbert, Ian H., Miles, Timothy J.“…Visceral leishmaniasis (VL) affects millions of people across the world, largely in developing nations. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2612por Freitas, Camila S., Oliveira-da-Silva, João A., Lage, Daniela P., Costa, Rafaella R., Mendonça, Débora V. C., Martins, Vívian T., Reis, Thiago A. R., Antinarelli, Luciana M. R., Machado, Amanda S., Tavares, Grasiele S. V., Ramos, Fernanda F., Coelho, Vinicio T. S., Brito, Rory C. F., Ludolf, Fernanda, Chávez-Fumagalli, Miguel A., Roatt, Bruno M., Ramos, Gabriela S., Munkert, Jennifer, Ottoni, Flaviano M., Campana, Priscilla R. V., Humbert, Maria V., Coimbra, Elaine S., Braga, Fernão C., Pádua, Rodrigo M., Coelho, Eduardo A. F.“…Treatment for visceral leishmaniasis (VL) is hampered mainly by drug toxicity, their high cost, and parasite resistance. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2613por Aguiar-Soares, Rodrigo Dian de Oliveira, Roatt, Bruno Mendes, Mathias, Fernando Augusto Siqueira, Reis, Levi Eduardo Soares, Cardoso, Jamille Mirelle de Oliveira, de Brito, Rory Cristiane Fortes, Ker, Henrique Gama, Corrêa-Oliveira, Rodrigo, Giunchetti, Rodolfo Cordeiro, Reis, Alexandre Barbosa“…Based on the foregoing, the LBSap vaccine would be suitable for further studies of phase III clinical trial in endemic areas with high prevalence and incidence of canine visceral leishmaniasis (VL) cases.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2614por Jubulis, Jennifer, Goddard, Amanda, Seiverling, Elizabeth, Kimball, Marc, McCarthy, Carol A“…BACKGROUND: Leishmaniasis has many clinical manifestations and treatment regimens, dependent on species and host. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2615por Priyamvada, Khushbu, Bindroo, Joy, Sharma, Madan Prashad, Chapman, Lloyd A. C., Dubey, Pushkar, Mahapatra, Tanmay, Hightower, Allen W., Bern, Caryn, Srikantiah, Sridhar“…BACKGROUND: With visceral leishmaniasis (VL) incidence at its lowest level since the 1960s, increasing attention has turned to early detection and investigation of outbreaks. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2616por Thomaz, Caio, de Mello, Cintia Xavier, Espíndola, Otávio de Melo, Shubach, Armando de Oliveira, Quintella, Leonardo Pereira, de Oliveira, Raquel Vasconcelos Carvalhaes, Duarte, Adriane Corrêa Gomes, Pimentel, Maria Inês Fernandes, Lyra, Marcelo Rosandiski, Marzochi, Mauro Celio de Almeida“…BACKGROUND: Cutaneous leishmaniasis (CL) is an infectious vector-borne disease caused by protozoa of the Leishmania genus that affects humans and animals. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2617por Singh, Om Prakash, Tiwary, Puja, Kushwaha, Anurag Kumar, Singh, Shakti Kumar, Singh, Dhiraj Kumar, Lawyer, Phillip, Rowton, Edgar, Chaubey, Rahul, Singh, Abhishek Kumar, Rai, Tulika Kumari, Fay, Michael P, Chakravarty, Jaya, Sacks, David, Sundar, Shyam“…BACKGROUND: Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal form of leishmaniasis caused by the protozoan parasite Leishmania donovani and transmitted by the bites of the vector sandfly Phlebotomus argentipes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2618por Bernardo, Lorena, Solana, Jose Carlos, Romero-Kauss, Alba, Sánchez, Carmen, Carrillo, Eugenia, Moreno, Javier“…The increasing use of immunosuppressants in areas where visceral leishmaniasis (VL) is endemic has increased the number of people susceptible to developing more severe forms of the disease. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2619por Dial, Natalie J., Medley, Graham F., Croft, Simon L., Mahapatra, Tanmay, Priyamvada, Khushbu, Sinha, Bikas, Palmer, Lucy, Terris-Prestholt, Fern“…BACKGROUND: Effective case identification strategies are fundamental to capturing the remaining visceral leishmaniasis (VL) cases in India. To inform government strategies to reach and sustain elimination benchmarks, this study presents costs of active- and passive- case detection (ACD and PCD) strategies used in India’s most VL-endemic state, Bihar, with a focus on programme outcomes stratified by district-level incidence. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2620por Kupani, Manu, Sharma, Smriti, Pandey, Rajeev Kumar, Kumar, Rajiv, Sundar, Shyam, Mehrotra, Sanjana“…Previous studies have shown suppressed NO production during Leishmania donovani infection, the causative agent of visceral leishmaniasis (VL). Availability of L-Arginine, a semi-essential amino acid is required for inducible nitric oxide synthase (iNOS) mediated NO production. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto